Cargando…

COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms

The COVID-19 outbreak had a significant impact on business cash flows and investment activities. This paper examined the COVID-19 impact on Chinese business investment in 3326 A-share listed quarterly financial reports, from which it was found that the negative relationship was more pronounced in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jie, Hou, Jack, Wang, Cangyu, Liu, HaiYue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760635/
https://www.ncbi.nlm.nih.gov/pubmed/36567767
http://dx.doi.org/10.1016/j.asieco.2021.101320
_version_ 1784852520200306688
author Jiang, Jie
Hou, Jack
Wang, Cangyu
Liu, HaiYue
author_facet Jiang, Jie
Hou, Jack
Wang, Cangyu
Liu, HaiYue
author_sort Jiang, Jie
collection PubMed
description The COVID-19 outbreak had a significant impact on business cash flows and investment activities. This paper examined the COVID-19 impact on Chinese business investment in 3326 A-share listed quarterly financial reports, from which it was found that the negative relationship was more pronounced in the large, eastern Chinese state-owned firms. Using a propensity score matching method and difference-in-differences estimation, corporate financial flexibility was also examined, with the results indicating that high cash flexibility provided a buffer that allowed firms to better deal with adverse external shocks as the firms that had high cash flexibility were able to significantly increase their investments after the COVID-19 outbreak. Various robustness tests were conducted, all of which verified the robustness of the results. Overall, the empirical results provided evidence that the COVID-19 pandemic in China had a negative impact on Chinese listed firms, and verified the vital role of flexible financial reserves for firm survival and development during crises.
format Online
Article
Text
id pubmed-9760635
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97606352022-12-19 COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms Jiang, Jie Hou, Jack Wang, Cangyu Liu, HaiYue J Asian Econ Article The COVID-19 outbreak had a significant impact on business cash flows and investment activities. This paper examined the COVID-19 impact on Chinese business investment in 3326 A-share listed quarterly financial reports, from which it was found that the negative relationship was more pronounced in the large, eastern Chinese state-owned firms. Using a propensity score matching method and difference-in-differences estimation, corporate financial flexibility was also examined, with the results indicating that high cash flexibility provided a buffer that allowed firms to better deal with adverse external shocks as the firms that had high cash flexibility were able to significantly increase their investments after the COVID-19 outbreak. Various robustness tests were conducted, all of which verified the robustness of the results. Overall, the empirical results provided evidence that the COVID-19 pandemic in China had a negative impact on Chinese listed firms, and verified the vital role of flexible financial reserves for firm survival and development during crises. Elsevier Inc. 2021-08 2021-04-27 /pmc/articles/PMC9760635/ /pubmed/36567767 http://dx.doi.org/10.1016/j.asieco.2021.101320 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jiang, Jie
Hou, Jack
Wang, Cangyu
Liu, HaiYue
COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title_full COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title_fullStr COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title_full_unstemmed COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title_short COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
title_sort covid-19 impact on firm investment—evidence from chinese publicly listed firms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760635/
https://www.ncbi.nlm.nih.gov/pubmed/36567767
http://dx.doi.org/10.1016/j.asieco.2021.101320
work_keys_str_mv AT jiangjie covid19impactonfirminvestmentevidencefromchinesepubliclylistedfirms
AT houjack covid19impactonfirminvestmentevidencefromchinesepubliclylistedfirms
AT wangcangyu covid19impactonfirminvestmentevidencefromchinesepubliclylistedfirms
AT liuhaiyue covid19impactonfirminvestmentevidencefromchinesepubliclylistedfirms